Cargando…

Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study

BACKGROUND: Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched patients who received either TACE, multimodal thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schöniger-Hekele, Maximilian, Kettenbach, Joachim, Peck-Radosavljevic, Markus, Müller, Christian
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779805/ https://www.ncbi.nlm.nih.gov/pubmed/19887008 http://dx.doi.org/10.1186/1756-9966-28-142

Ejemplares similares

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Review article: systemic treatment of hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2018)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience
por: Peck-Radosavljevic, Markus, et al.
Publicado: (2020)

Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells
por: Wittmann, Philipp, et al.
Publicado: (2015)

The impact of thyroid hormones on patients with hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2017)

Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years
por: Kamogawa-Schifter, Yumiko, et al.
Publicado: (2018)

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
por: Tiberg, Fredrik, et al.
Publicado: (2015)

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Changes in the Epidemiology of Hepatocellular Carcinoma in Carinthia, Austria, 2012–2023
por: Hucke, Florian, et al.
Publicado: (2023)

Predictors for success in renal denervation–a single centre retrospective analysis
por: Reshetnik, Alexander, et al.
Publicado: (2018)

Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series
por: Brindle, Kayleigh, et al.
Publicado: (2023)

Octreotide scanning in the detection of metastatic renal cell carcinoma
por: McCloskey, Marguerite C., et al.
Publicado: (2008)

Drug Therapy for Advanced-Stage Liver Cancer
por: Peck-Radosavljevic, Markus
Publicado: (2014)

Editorial
por: Peck-Radosavljevic, Markus
Publicado: (2020)

Author Correction: Predictors for success in renal denervation–a single centre retrospective analysis
por: Reshetnik, Alexander, et al.
Publicado: (2019)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
por: Li, Shuren, et al.
Publicado: (2017)

Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
por: Haider, Christine, et al.
Publicado: (2018)

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
por: Cebon, J
Publicado: (2006)

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
por: Cebon, J, et al.
Publicado: (2007)

Octreotide Conjugates for Tumor Targeting and Imaging
por: Figueras, Eduard, et al.
Publicado: (2019)

Octreotide Uptake in Parathyroid Adenoma
por: Karaçavuş, Seyhan, et al.
Publicado: (2012)

Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
por: Caraglia, M, et al.
Publicado: (2011)

Citalopram/octreotide: Carcinoid heart disease, unmasking of carcinoid syndrome and development of octreotide resistance: case report
Publicado: (2021)

Therapeutic Applications of Octreotide in Pediatric Patients
por: Al-Hussaini, Abdulrahman, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Visualization of Gallbladder with In-111 Octreotide Scan
por: Özülker, Filiz, et al.
Publicado: (2015)

Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica, Giuliana, et al.
Publicado: (2020)

Octreotide Infusion for the Treatment of Congenital Chylothorax
por: Kobeisy, Sumayyah Ahmed Nezar, et al.
Publicado: (2020)

Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021)

Role of octreotide in small bowel bleeding
por: Khedr, Anwar, et al.
Publicado: (2022)

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study
por: Verset, G, et al.
Publicado: (2007)

Sorafenib for the Treatment of Hepatocellular Carcinoma: A Single-centre Real-world Study
por: Hanzel, Jurij, et al.
Publicado: (2020)

Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid
por: Christian, J A, et al.
Publicado: (2003)

EGFR has a tumor-promoting role in liver macrophages during hepatocellular carcinoma formation
por: Lanaya, Hanane, et al.
Publicado: (2014)

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
por: Nilsson, O., et al.
Publicado: (1998)

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
por: Rimassa, Lorenza, et al.
Publicado: (2017)

Effect of Octreotide on Lymphorrhea in Patients After Modified Radical Mastectomy for Carcinoma Breast: A Randomized Controlled Trial
por: Prajapati, Sahaj, et al.
Publicado: (2021)

Octreotide-induced thrombocytopenia: a case report
por: Rashidi, Armin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uuj5j64tvodmg6014366cd8je4